ADAM8 as a drug target in pancreatic cancerUwe Schlomann, Jörg W. Bartsch|Nature Communications|2015Cited by 124
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its AggressivenessAgnes Schäfer, Jörg W. Bartsch|Frontiers in Oncology|2022Cited by 35
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma CellsKai Zhao, Jörg W. Bartsch|International Journal of Molecular Sciences|2021Cited by 30
Identification of Dysregulated microRNAs in Glioblastoma Stem-like CellsLara Evers, Jörg W. Bartsch|Brain Sciences|2023Cited by 8